Literature DB >> 17296919

Neuropsychological abnormalities in patients with dementia in CRF 01_AE HIV-1 infection.

V G Valcour1, P Sithinamsuwan, S Nidhinandana, S Thitivichianlert, S Ratto-Kim, W Apateerapong, B T Shiramizu, M S Desouza, S T Chitpatima, G Watt, T Chuenchitra, K R Robertson, R H Paul, J C McArthur, J H Kim, C M Shikuma.   

Abstract

HIV-associated dementia (HAD) is not firmly established in patients with circulating recombinant form (CRF) 01_AE HIV-1. In this study, we compared neuropsychological performance among 15 Thai individuals with HAD, 15 Thai individuals without HAD, and 30 HIV-negative control subjects. HIV-1 participants were highly active anti-retroviral therapy naive and matched by age, education, and CD4 count. Neuropsychological testing abnormalities were identified in most cognitive domains among HAD vs HIV-negative participants, confirming the presence of HAD in CRF01_AE.

Entities:  

Mesh：

Year:  2007        PMID： 17296919     DOI： 10.1212/01.wnl.0000253196.78193.c7

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  18 in total

1.  Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy.

Authors:  B Shiramizu; J Ananworanich; T Chalermchai; U Siangphoe; D Troelstrup; C Shikuma; V De Grutolla; P Sithinamsuwan; P Praihirunkit; S Rattanamanee; V Valcour
Journal:  J Neurovirol       Date:  2011-12-30       Impact factor: 2.643

2.  HIV DNA in CD14+ reservoirs is associated with regional brain atrophy in patients naive to combination antiretroviral therapy.

Authors:  Kalpana J Kallianpur; Victor G Valcour; Sukalaya Lerdlum; Edgar Busovaca; Melissa Agsalda; Pasiri Sithinamsuwan; Thep Chalermchai; James L K Fletcher; Somporn Tipsuk; Cecilia M Shikuma; Bruce T Shiramizu; Jintanat Ananworanich
Journal:  AIDS       Date:  2014-07-17       Impact factor: 4.177

3.  Neurocognitive impairment in patients randomized to second-line lopinavir/ritonavir-based antiretroviral therapy vs. lopinavir/ritonavir monotherapy.

Authors:  Torsak Bunupuradah; Ploenchan Chetchotisakd; Supunnee Jirajariyavej; Victor Valcour; Chureeratana Bowonwattanuwong; Warangkana Munsakul; Virat Klinbuayaem; Wisit Prasithsirikul; Jiratchaya Sophonphan; Apicha Mahanontharit; Bernard Hirschel; Sorakij Bhakeecheep; Kiat Ruxrungtham; Jintanat Ananworanich
Journal:  J Neurovirol       Date:  2012-09-20       Impact factor: 2.643

4.  Central nervous system viral invasion and inflammation during acute HIV infection.

Authors:  Victor Valcour; Thep Chalermchai; Napapon Sailasuta; Mary Marovich; Sukalaya Lerdlum; Duanghathai Suttichom; Nijasri C Suwanwela; Linda Jagodzinski; Nelson Michael; Serena Spudich; Frits van Griensven; Mark de Souza; Jerome Kim; Jintanat Ananworanich
Journal:  J Infect Dis       Date:  2012-05-02       Impact factor: 5.226

5.  Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study.

Authors:  Wadchara Pumpradit; Jintanat Ananworanich; Sermsak Lolak; Cecilia Shikuma; Robert Paul; Umaporn Siangphoe; Nithima Chaoniti; Peeraporn Kaew-On; Robert Paris; Kiat Ruxrungtham; Victor Valcour
Journal:  J Neurovirol       Date:  2010-02       Impact factor: 2.643

6.  HIV DNA and cognition in a Thai longitudinal HAART initiation cohort: the SEARCH 001 Cohort Study.

Authors:  V G Valcour; B T Shiramizu; P Sithinamsuwan; S Nidhinandana; S Ratto-Kim; J Ananworanich; U Siangphoe; J H Kim; M de Souza; V Degruttola; R H Paul; C M Shikuma
Journal:  Neurology       Date:  2009-03-17       Impact factor: 9.910

7.  Trail Making Test A improves performance characteristics of the International HIV Dementia Scale to identify symptomatic HAND.

Authors:  Thep Chalermchai; Victor Valcour; Pasiri Sithinamsuwan; Suteeraporn Pinyakorn; David Clifford; Robert H Paul; Somporn Tipsuk; James L K Fletcher; Victor Degruttola; Silvia Ratto-Kim; Nicholas Hutchings; Cecilia Shikuma; Jintanat Ananworanich
Journal:  J Neurovirol       Date:  2013-03-13       Impact factor: 2.643

8.  Neuronal-Glia Markers by Magnetic Resonance Spectroscopy in HIV Before and After Combination Antiretroviral Therapy.

Authors:  Napapon Sailasuta; Jintanat Ananworanich; Sukalaya Lerdlum; Pasiri Sithinamsuwan; James L K Fletcher; Somporn Tipsuk; Mantana Pothisri; Tanate Jadwattanakul; Supunnee Jirajariyavej; Thep Chalermchai; Stephanie Catella; Edgar Busovaca; Akash Desai; Robert Paul; Victor Valcour
Journal:  J Acquir Immune Defic Syndr       Date:  2016-01-01       Impact factor: 3.731

9.  Global NeuroAIDS roundtable.

Authors:  Jeymohan Joseph; Cristian L Achim; Michael J Boivin; Bruce J Brew; David B Clifford; Deborah A Colosi; Ronald J Ellis; Robert K Heaton; Amadou Gallo-Diop; Igor Grant; Georgette D Kanmogne; Mahendra Kumar; Scott Letendre; Thomas D Marcotte; Avindra Nath; Carlos A Pardo; Robert H Paul; Lynn Pulliam; Kevin Robertson; Walter Royal; Ned Sacktor; Pasiri Sithinamsuwan; Davey M Smith; Victor Valcour; Brian Wigdahl; Charles Wood
Journal:  J Neurovirol       Date:  2013-01-26       Impact factor: 2.643

10.  NeuroAIDS in the Asia Pacific Region.

Authors:  Edwina J Wright; Michael Nunn; Jeymohan Joseph; Kevin Robertson; Luxshimi Lal; Bruce J Brew
Journal:  J Neurovirol       Date:  2008-11       Impact factor: 2.643
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.